These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25171765)

  • 1. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
    Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
    J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in mass spectrometry proteomics for biomedical research.
    Li X; Wang W; Chen J
    Sci China Life Sci; 2017 Oct; 60(10):1093-1113. PubMed ID: 29039124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four areas of engagement requiring strengthening in modern proteomics today.
    Fehniger TE; Boja ES; Rodriguez H; Baker MS; Marko-Varga G
    J Proteome Res; 2014 Dec; 13(12):5310-8. PubMed ID: 25405748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research.
    Tyanova S; Cox J
    Methods Mol Biol; 2018; 1711():133-148. PubMed ID: 29344888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
    Hernandez-Valladares M; Bruserud Ø; Selheim F
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.
    Cohen Freue GV; Meredith A; Smith D; Bergman A; Sasaki M; Lam KK; Hollander Z; Opushneva N; Takhar M; Lin D; Wilson-McManus J; Balshaw R; Keown PA; Borchers CH; McManus B; Ng RT; McMaster WR;
    PLoS Comput Biol; 2013 Apr; 9(4):e1002963. PubMed ID: 23592955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.
    Hawkridge AM; Muddiman DC
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():265-77. PubMed ID: 20636062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.
    Boja ES; Rodriguez H
    Korean J Lab Med; 2011 Apr; 31(2):61-71. PubMed ID: 21474978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry.
    Yocum AK; Chinnaiyan AM
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):145-57. PubMed ID: 19279071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical proteomics towards multiomics in cancer.
    Creighton CJ
    Mass Spectrom Rev; 2024; 43(6):1255-1269. PubMed ID: 36495097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer proteomics.
    Tan HT; Lee YH; Chung MC
    Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating protein biomarkers for gastric cancers: A catalogue of mass spectrometry-based markers and assessment of their suitability for targeted proteomics applications.
    Ramesh P; Nisar M; Neha ; Ammankallu S; Babu S; Nandakumar R; Abhinand CS; Prasad TSK; Codi JAK; Raju R
    J Proteomics; 2024 Aug; 306():105262. PubMed ID: 39047941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.